In a current article revealed in Nanomaterials, researchers investigated the potential of chitosan nanoparticles (CHNPs) as a supply system for curcumin, aiming to enhance its therapeutic efficacy towards breast most cancers.
Picture Credit score: CI Images/Shutterstock.com
Background
Chitosan, a biopolymer obtained from chitin, is thought for its biocompatibility, biodegradability, and skill to encapsulate numerous therapeutic brokers. The ionic gelation methodology is a broadly used method for synthesizing chitosan nanoparticles, permitting for the formation of secure nanosuspensions. The incorporation of curcumin into chitosan nanoparticles is anticipated to reinforce its solubility and bioavailability, thereby enhancing its anti-cancer results.
Whereas curcumin has been proven to induce apoptosis in most cancers cells and inhibit tumor development, its poor pharmacokinetic properties restrict its medical utility.
The Present Research
To synthesize the CHNPs, tripolyphosphate (TPP) was used as a cross-linking agent, facilitating the ionic gelation of chitosan and leading to nanoparticle formation. These CHNPs have been then characterised utilizing dynamic mild scattering (DLS) to measure particle measurement and zeta potential. A zeta potential measurement was carried out to evaluate nanoparticle stability in suspension, with values above +30 mV indicating good stability attributable to electrostatic repulsion.
To load curcumin into the chitosan nanoparticles, a selected weight ratio of curcumin to chitosan was established, and curcumin was encapsulated throughout the nanoparticles. The combination was centrifuged to separate unencapsulated curcumin from the nanoparticle suspension. The supernatant was collected, and the quantity of curcumin within the supernatant was quantified utilizing UV-visible spectrophotometry to calculate encapsulation effectivity.
In vitro research have been performed utilizing breast most cancers cell traces, which have been cultured in a development medium supplemented with fetal bovine serum (FBS) and antibiotics. The cytotoxicity of the curcumin-loaded CHNPs was assessed utilizing the MTT assay, the place cells have been seeded in 96-well plates and handled with various concentrations of free curcumin and Cur-CHNPs. Absorbance was measured at 570 nm utilizing a microplate reader, and the share of cell viability was calculated.
For in vivo research, male BALB/c mice have been acclimatized for one week earlier than the experiment. Breast most cancers was induced by subcutaneously injecting the mice with a selected variety of most cancers cells. As soon as the tumors reached a predetermined measurement, the mice have been randomly assigned to completely different therapy teams, together with these receiving free curcumin and people receiving Cur-CHNPs. The remedies have been administered orally, with dosages calculated based mostly on the mice’s physique weight.
Tumor development was monitored by measuring the size of the tumors. Hematological and biochemical parameters have been evaluated to evaluate the security and toxicity of the remedies. Blood samples have been collected, and numerous assays have been performed to research liver and kidney operate, in addition to full blood counts.
Outcomes and Dialogue
Physicochemical characterization revealed that the optimized chitosan nanoparticles have been roughly 85 nm in measurement, whereas the curcumin-loaded nanoparticles measured round 118 nm. The optimistic zeta potential, which is favorable for mobile uptake, indicated that the nanoparticles have been well-suited for therapeutic use.
The examine demonstrated that Cur-CHNPs had enhanced solubility in aqueous options in comparison with free curcumin, suggesting improved bioavailability. Lengthy-term stability assessments confirmed that the nanoparticles maintained their measurement with out aggregation over 74 days, highlighting their potential for sustained launch purposes.
In vitro research indicated that Cur-CHNPs considerably inhibited the proliferation of breast most cancers cells extra successfully than free curcumin. This impact was attributed to the induction of apoptosis and cell cycle arrest, which have been confirmed by means of numerous assays.
In vivo experiments supported these findings, displaying a marked discount in tumor quantity in mice handled with Cur-CHNPs in comparison with management teams. The examine additionally assessed the acute and subchronic toxicity of Cur-CHNPs, revealing no vital antagonistic results on the hematological and biochemical parameters of the handled mice. These outcomes underscore the security and efficacy of chitosan nanoparticles as a supply system for curcumin in breast most cancers remedy.
The flexibility of Cur-CHNPs to reinforce curcumin’s solubility and bioavailability presents a promising method to overcoming the restrictions related to conventional curcumin administration. The examine additionally highlighted the potential of chitosan nanoparticles as a flexible platform for delivering different therapeutic brokers, paving the way in which for future analysis on this space.
Conclusion
In conclusion, the in vitro and in vivo outcomes point out that Cur-CHNPs not solely suppress tumor development but in addition exhibit a positive security profile, making them a promising candidate for additional improvement in most cancers remedy.
This analysis helps the usage of nanotechnology in enhancing drug supply programs, significantly for compounds with restricted medical applicability. Future research are required to discover the long-term results and potential medical purposes of Cur-CHNPs for numerous most cancers varieties.
Journal Reference
Mishra B., et al. (2024). Chitosan Nanoparticle-Mediated Supply of Curcumin Suppresses Tumor Progress in Breast Most cancers. Nanomaterials. DOI: 10.3390/nano14151294, https://www.mdpi.com/2079-4991/14/15/1294